Stryker Revenue 2006-2019 | SYK

Stryker annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Stryker revenue for the quarter ending June 30, 2019 was $3.650B, a 9.87% increase year-over-year.
  • Stryker revenue for the twelve months ending June 30, 2019 was $14.204B, a 8.93% increase year-over-year.
  • Stryker annual revenue for 2018 was $13.601B, a 9.3% increase from 2017.
  • Stryker annual revenue for 2017 was $12.444B, a 9.88% increase from 2016.
  • Stryker annual revenue for 2016 was $11.325B, a 13.86% increase from 2015.
Stryker Annual Revenue
(Millions of US $)
2018 $13,601
2017 $12,444
2016 $11,325
2015 $9,946
2014 $9,675
2013 $9,021
2012 $8,657
2011 $8,307
2010 $7,320
2009 $6,723
2008 $6,718
2007 $6,001
2006 $5,147
2005 $4,609
Stryker Quarterly Revenue
(Millions of US $)
Q2 2019 $3,650
Q1 2019 $3,516
Q4 2018 $3,796
Q3 2018 $3,242
Q2 2018 $3,322
Q1 2018 $3,241
Q4 2017 $3,471
Q3 2017 $3,006
Q2 2017 $3,012
Q1 2017 $2,955
Q4 2016 $3,157
Q3 2016 $2,833
Q2 2016 $2,840
Q1 2016 $2,495
Q4 2015 $2,715
Q3 2015 $2,420
Q2 2015 $2,432
Q1 2015 $2,379
Q4 2014 $2,618
Q3 2014 $2,389
Q2 2014 $2,363
Q1 2014 $2,305
Q4 2013 $2,468
Q3 2013 $2,151
Q2 2013 $2,212
Q1 2013 $2,190
Q4 2012 $2,338
Q3 2012 $2,052
Q2 2012 $2,106
Q1 2012 $2,161
Q4 2011 $2,215
Q3 2011 $2,031
Q2 2011 $2,046
Q1 2011 $2,015
Q4 2010 $1,995
Q3 2010 $1,768
Q2 2010 $1,758
Q1 2010 $1,799
Q4 2009 $1,834
Q3 2009 $1,653
Q2 2009 $1,634
Q1 2009 $1,601
Q4 2008 $1,718
Q3 2008 $1,653
Q2 2008 $1,713
Q1 2008 $1,634
Q4 2007 $1,658
Q3 2007 $1,453
Q2 2007 $1,464
Q1 2007 $1,426
Q4 2006 $1,333
Q3 2006 $1,231
Q2 2006 $1,262
Q1 2006 $1,321
Q4 2005 $1,016
Q3 2005 $1,172
Q2 2005 $1,219
Q1 2005 $1,203
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $80.541B $13.601B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.330B 27.69
Medtronic (MDT) Ireland $146.309B 20.54
Boston Scientific (BSX) United States $58.421B 28.34
Baxter (BAX) United States $44.378B 26.91
EssilorLuxottica Societe Anonyme (ESLOY) France $31.384B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.264B 18.09
Lonza Group Ag (LZAGY) Switzerland $24.906B 0.00
Coloplast (CLPBY) Denmark $24.894B 39.74
Terumo (TRUMY) Japan $22.254B 25.59
Smith & Nephew SNATS (SNN) United Kingdom $20.394B 0.00
ResMed (RMD) United States $18.779B 35.81
Sunny Optical Technology (SNPTF) China $16.365B 0.00
Bio-Rad Laboratories (BIO) United States $9.957B 53.38
Canopy Growth (CGC) Canada $9.657B 0.00
Insulet (PODD) United States $8.625B 511.07
Perrigo (PRGO) Ireland $7.714B 14.21
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.923B 20.64
Haemonetics (HAE) United States $6.394B 48.25
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.561B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.233B 0.00
Neogen (NEOG) United States $4.125B 68.48
NuVasive (NUVA) United States $3.402B 27.12
ICU Medical (ICUI) United States $3.401B 22.06
Hutchison China MediTech (HCM) China $2.728B 0.00
Quidel (QDEL) United States $2.681B 26.62
Agios Pharmaceuticals (AGIO) United States $2.216B 0.00
National Vision Holdings (EYE) United States $2.181B 47.07
Cardiovascular Systems (CSII) United States $1.821B 0.00
Aphria (APHA) $1.659B 0.00
VAREX IMAGING (VREX) United States $1.115B 25.70
AtriCure (ATRC) United States $0.998B 0.00
Lantheus Holdings (LNTH) United States $0.977B 25.69
Omeros (OMER) United States $0.949B 0.00
Phibro Animal Health (PAHC) United States $0.894B 14.54
Eagle Pharmaceuticals (EGRX) United States $0.803B 20.47
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.763B 18.03
Cerus (CERS) United States $0.755B 0.00
LeMaitre Vascular (LMAT) United States $0.702B 41.63
MacroGenics (MGNX) United States $0.652B 0.00
Surmodics (SRDX) United States $0.640B 121.56
Quanterix (QTRX) United States $0.638B 0.00
TG Therapeutics (TGTX) United States $0.624B 0.00
OraSure Technologies (OSUR) United States $0.469B 21.71
Meridian Bioscience (VIVO) United States $0.427B 13.32
BioLife Solutions (BLFS) United States $0.392B 128.81
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.391B 0.00
Owens & Minor (OMI) United States $0.378B 11.32
Utah Medical Products (UTMD) United States $0.370B 27.14
United Health Products (UEEC) United States $0.330B 0.00
Zynex (ZYXI) United States $0.290B 30.83
Bovie Medical (APYX) United States $0.243B 0.00
Rockwell Medical (RMTI) United States $0.204B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Vapotherm (VAPO) United States $0.165B 0.00
Fonar (FONR) United States $0.150B 10.69
Chimerix (CMRX) United States $0.141B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
InfuSystems Holdings (INFU) United States $0.106B 0.00
United-Guardian (UG) United States $0.087B 20.54
MRI Interventions (MRIC) United States $0.067B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
Nephros (NEPH) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.014B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00